Business Context and Reporting Period
This Form 8-K Current Report was filed by Stereotaxis, Inc. on October 22, 2012. The report discloses corporate governance changes and regulatory disclosures effective as of the filing date.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on corporate events rather than financial performance data.
Material Changes
- Board Election: Dr. Euan S. Thomson was elected to the Board of Directors on October 22, 2012.
- Compensation: Dr. Thomson will receive 20,000 restricted stock units and other compensation consistent with the Company's standard non-management Director compensation plan.
- Related Party Transactions: The Company reported no transactions involving Dr. Thomson exceeding $120,000 since January 1, 2009, in which he had a material interest.
Guidance, Outlook, and Risks
The filing includes standard forward-looking statements regarding future activities and performance, noting that actual results may differ materially due to risks and uncertainties. The Company explicitly states it does not intend to update these statements except as required by law. No specific financial guidance or operational outlook was provided in this document.
Investor Verification Checklist
- Verify Dr. Euan S. Thomson's professional background and potential conflicts of interest.
- Review the Company's 2012 Proxy Statement for details on the "Director Compensation" plan referenced for Dr. Thomson.
- Confirm the absence of undisclosed related-party transactions involving the new director.
- Check subsequent filings for committee assignments for Dr. Thomson, which were pending at the time of this report.